Skip to main content
SpringerLink
Log in

Vitreous Surgery for Diabetic Macular Edema—its Prognosis and Correlation between Preoperative Systemic and Ocular Conditions and Visual Outcome

  • Original Article
  • Published:
Annals of Ophthalmology

Abstract

The effectiveness of vitreous surgery for diabetic macular edema (DME), and the correlation between the preoperative systemic and ocular conditions and the visual outcome following vitrectomy were studied. Visual acuity improved in about 50% of the eyes. Both visual acuity and foveal thickness recovered 12 months after surgery and the improvement of visual acuity occurred later than the recovery of foveal thickness. The preoperative systemic condition does not affect the improvement of visual acuity, and thus it is not necessary to wait for good diabetic control if surgery is indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995;102:7–16

    PubMed  CAS  Google Scholar 

  2. Vitale S, Maguire MG, Murphy RP, et al. Clinically significant macular edema in type I diabetes. Incidence and risk factors. Ophthalmology 1995;102:1170–1176

    PubMed  CAS  Google Scholar 

  3. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic maculae edema. Ophthalmology 1984;91:1464–1474

    PubMed  CAS  Google Scholar 

  4. The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986

    Article  Google Scholar 

  5. Zander E, Herfurth S, Bohl B, et al. Maculopathy in patients with diabetes mellitus type 1 and type 2: Association with risk factors. Br J Ophthalmol 2000;84:871–876

    Article  PubMed  CAS  Google Scholar 

  6. Aiello ST, Pasquale LR, Thieme H. Vascular endothelial growth factor in ocular fluid of patient with diabetic retinopathy and other retinal diseases. N Engl J Med 1994;331:1480–1487

    Article  PubMed  CAS  Google Scholar 

  7. Aiello LP, Bursell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 1997;46:1473–1480

    Article  PubMed  CAS  Google Scholar 

  8. Tanaka Y, Katoh S, Hori S, et al. Vascular endothelial growth factor in diabetic retinopathy. Lancet 1997;349:1520

    Article  PubMed  CAS  Google Scholar 

  9. Kaiser PK, Riemann CD, Sears JE, et al. Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 2001;131:44–49

    Article  PubMed  CAS  Google Scholar 

  10. Early treatment diabetic retinopathy study research group. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 1985;103:1796–1806

    Google Scholar 

  11. McDonald HR, Schatz H. Grid photocoagulation for diffuse macular edema. Retina 1985;5:65–72

    Article  PubMed  CAS  Google Scholar 

  12. Lewis H, Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753–759

    PubMed  CAS  Google Scholar 

  13. Karacorlu S, Burumcek E, Karacorlu M, et al. Treatment of diabetic macular edema: a comparison between argon and dye lasers. Ann Ophthalmol 1993;25:138–141

    PubMed  CAS  Google Scholar 

  14. Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996;122:258–260

    PubMed  CAS  Google Scholar 

  15. Horbour JW, Smiddy WE, Flynn HW Jr, et al. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996;121:405–413

    Google Scholar 

  16. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920–927

    Article  PubMed  Google Scholar 

  17. Gandorfer A, Messmer EM, Ulbig MW, et al. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000;20:126–133

    Article  PubMed  CAS  Google Scholar 

  18. Nasrallah FP, Jalkh AE, Van Coppenolle F, et al. The role of the vitreous in diabetic macular edema. Ophthalmology 1988;95:1335–1339

    PubMed  CAS  Google Scholar 

  19. Yamamoto T, Hitani K, Tsukahara I, et al. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. Am J Ophthalmol 2003;135:14–19

    Article  PubMed  Google Scholar 

  20. Ikeda T, Sato K, Katano T, et al. Improvement of visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina 2000;20:220–222

    Article  PubMed  CAS  Google Scholar 

  21. Lovestam-Adrian M, Larsoon J. Vitrectomy seems to be beneficial for advanced diffuse diabetic macular edema not responding to laser treatment. Int Ophthalmol 2005;26:21–26

    Article  PubMed  Google Scholar 

  22. Shah SP, Patel M, Thomas D, et al. Factors predicting outcome of vitrectomy for diabetic macular edema: results of a prospective study. Br J Ophthalmol 2006;90:33–36

    Article  PubMed  CAS  Google Scholar 

  23. Chaurasia RK, Singh R, Agrawal JK, et al. Sex hormones and diabetic retinopathy. Ann Ophthalmol 1993;25:227–230

    PubMed  CAS  Google Scholar 

  24. Hooymans JM, Ballegooie EV, Schweitzer NM, et al. Worsening of diabetic retinopathy with strict control of blood sugar. Lancet 1982;2:438

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, 279-0021, Japan

    Noriko Hatano MD, Atsushi Mizota MD & Minoru Tanaka MD

Authors
  1. Noriko Hatano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atsushi Mizota MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Minoru Tanaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atsushi Mizota MD.

Additional information

Drs. Hatano, Mizota, and Tanaka are from the Department of Ophthalmology, Juntendo University, Urayasu Hospital 2-1-1 Tomioka, Urayasu, 279-0021, Japan.

The authors have stated that they do not have a significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article. The authors also do not discuss the use of off-label products, which includes unlabeled, unapproved, or investigative products or devices.

The studied the effectiveness of vitreous surgery for diabetic macular edema, and the correlation between the preoperative systemic and ocular conditions and the visual outcome following vitrectomy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hatano, N., Mizota, A. & Tanaka, M. Vitreous Surgery for Diabetic Macular Edema—its Prognosis and Correlation between Preoperative Systemic and Ocular Conditions and Visual Outcome. Ann Ophthalmol 39, 222–227 (2007). https://doi.org/10.1007/s12009-007-0027-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12009-007-0027-4

Keywords

Search

Navigation